Capricor Therapeutics (CAPR) Q2 2026 Earnings

12MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.59
-0.5
-0.41
-0.32

Details

Expected EPS
-0.522857
Actual EPS
-0.59
Surprise EPS
-0.07
Surprise Percent
+12.84%

Description

Capricor Therapeutics (CAPR) has reported earnings of -0.59 per share for Q2 2026.

0 Comments

Share your thoughts